Purchase Order 75N92021P00145
Award Date 6/16/21
Potential Completion Date 6/30/22
Potential Value $66K
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
New Hyde Park, NY 11042, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Heart Lung and Blood Institute awarded a $112,198.00 firm fixed price purchase order to Cerba Research USA Inc., a for-profit organization, to procure the services of BARC to assay serum biomarkers. The work is to be performed in Bethesda, Maryland and there are no set-aside designations or subcontractors indicated. Cerba Research USA Inc. is a clinical trial and laboratory services provider that...
- This contract was awarded by the Department of Health and Human Services' National Institutes of Health National Human Genome Research Institute to Cerba Research USA Inc., a for-profit organization that provides clinical trial and laboratory services to support biomedical research. The $108,028.00 fixed-price purchase order is for Cerba Research to provide clinical laboratory testing and associated data management services, to be performed at the company's New York laboratory. No subcontractors...
- This firm fixed-price purchase order was awarded by the National Human Genome Research Institute, a civilian agency within the U.S. Department of Health and Human Services, to Cerba Research USA, Inc. for $126,198.00. The contract is for the provision of a clinical chemistry panel to support biomedical research in West African populations. The period of performance runs through August 17, 2025. This award is not designated as a set-aside contract. Cerba Research USA, Inc. is a for-profit...
- This is a firm fixed-price delivery order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the U.S. Department of Health and Human Services, to Cerba Research USA, Inc., a for-profit organization. The $529,892 award will fund clinical central laboratory services in support of three NIAID clinical protocols related to infectious diseases. This work will be performed at Cerba Research's facility in New Hyde Park, New York. The award is not associated...
- This is a firm fixed-price delivery order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the U.S. Department of Health and Human Services, to Cerba Research USA, Inc. for SARS-CoV-2 testing support. The total award value is $1,382,498.14, with a total ceiling of $1,615,094.14. The period of performance runs through December 31, 2023. This award is not associated with a larger contract vehicle, and no set-aside designation was used. Cerba...
- This federal contract award, valued at $1,013,722.26, was issued by the National Heart Lung and Blood Institute, a civilian agency, to Lovelace Biomedical and Environmental Research Institute, Inc. (LBERI), a not-for-profit contract research organization. The award is for the GTRP Pharmacology-Toxicology Core Lab, Task Order 6, Task Area B, with a period of performance through April 15, 2017. The contract is a cost-plus-fixed-fee delivery order, without a set-aside designation. LBERI, a...
- This federal contract award was issued by the National Heart Lung and Blood Institute (NHLBI), a component of the National Institutes of Health (NIH), to Lovelace Biomedical and Environmental Research Institute, Inc. (LBERI), a subsidiary of Lovelace Biomedical Research Institute. The $203,807.96 contract is a delivery order for Task Area A under the Pharmacology-Toxicology Core Lab task order 7 of the NHLBI's Gene Therapy Resource Program (GTRP). The work, which has no set-aside designation,...
- The National Heart, Lung and Blood Institute (NHLBI) awarded a $790,996.52 firm fixed price purchase order to Comprehensive Research Solutions LLC on July 16, 2021, for clinical research monitoring support services. The contract, which was not set aside for any designated group, was completed by May 31, 2022, and performed in Bethesda, Maryland. Comprehensive Research Solutions LLC is a women-owned small business founded and operated by physicians with extensive clinical research experience,...
- This firm-fixed-price purchase order contract was awarded to CDI Laboratories Inc., a small disadvantaged business, to provide its proprietary HUPROT V4.0 ARRAY protein microarray product and related antibody profiling and analysis services to the National Heart Lung and Blood Institute (NHLBI), a component of the National Institutes of Health (NIH). The $121,379.50 contract supports biomedical research efforts, particularly in the areas of infectious diseases, heart/lung disorders, aging, and...
- The National Heart, Lung and Blood Institute of the National Institutes of Health, Department of Health and Human Services, awarded a $224,000 purchase order to Cell Signaling Technology, Inc. of Danvers, Massachusetts for proteome analysis services. The one-year contract, running from August 2024 through August 2025, is for a firm fixed price and will be performed in Danvers. As part of its mission to advance scientific and medical achievements that eliminate preventable disease, the NHLBI...